Modeling of skeletal development and diseases using human pluripotent stem cells

被引:0
|
作者
Hojo, Hironori [1 ,2 ]
Tani, Shoichiro [3 ]
Ohba, Shinsuke [4 ]
机构
[1] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Div Clin Biotechnol, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138655, Japan
[3] Univ Texas Southwestern Med Ctr, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA
[4] Osaka Univ, Grad Sch Dent, Dept Tissue & Dev Biol, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
human pluripotent stem cells; skeletal development; disease modeling; osteoblasts; chondrocytes; ON-A-CHIP; HUMAN SEGMENTATION CLOCK; NEURAL CREST CELLS; OSTEOBLAST DIFFERENTIATION; BONE REGENERATION; SHH ESTABLISHES; AXIAL SKELETON; FEEDBACK LOOP; MESODERM; BMP;
D O I
10.1093/jbmr/zjae178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human skeletal elements are formed from distinct origins at distinct positions of the embryo. For example, the neural crest produces the facial bones, the paraxial mesoderm produces the axial skeleton, and the lateral plate mesoderm produces the appendicular skeleton. During skeletal development, different combinations of signaling pathways are coordinated from distinct origins during the sequential developmental stages. Models for human skeletal development have been established using human pluripotent stem cells (hPSCs) and by exploiting our understanding of skeletal development. Stepwise protocols for generating skeletal cells from different origins have been designed to mimic developmental trails. Recently, organoid methods have allowed the multicellular organization of skeletal cell types to recapitulate complicated skeletal development and metabolism. Similarly, several genetic diseases of the skeleton have been modeled using patient-derived induced pluripotent stem cells and genome-editing technologies. Model-based drug screening is a powerful tool for identifying drug candidates. This review briefly summarizes our current understanding of the embryonic development of skeletal tissues and introduces the current state-of-the-art hPSC methods for recapitulating skeletal development, metabolism, and diseases. We also discuss the current limitations and future perspectives for applications of the hPSC-based modeling system in precision medicine in this research field. Human bones have different origins in the embryo: facial bones originate from the neural crest, axial skeleton from the paraxial mesoderm, and limb bones from the lateral plate mesoderm. Human stem cells have been used to model bone development by mimicking the developmental processes. Recent advancements, such as organoid methods, have helped recreate complex bone development. Genetic bone diseases have also been studied using stem cells and gene editing technology. These models hold promise for improving precision medicine. This review overviews our understanding of bone development, introduces current advancements, and provides future perspectives for bone and stem cell research.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease
    Heslop, James A.
    Duncan, Stephen A.
    HEPATOLOGY, 2019, 69 (03) : 1306 - 1316
  • [32] Modeling human hematopoietic cell development from pluripotent stem cells
    Kardel, Melanie D.
    Eaves, Connie J.
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : 601 - 611
  • [33] Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells
    van Hugte, Eline
    Kasri, Nael Nadif
    FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS, 2019, 1192 : 297 - 312
  • [34] Using human pluripotent stem cells to dissect trophoblast development
    Suzuki, Daisuke
    Lan, Kuan-Chun
    Takashima, Yasuhiro
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2023, 83
  • [35] Modeling Gastrointestinal and Liver Genetic Diseases Using Induced Pluripotent Stem Cells
    Gianotti-Sommer, Andreia
    Sommer, Cesar
    Mostoslavsky, Gustavo
    GASTROENTEROLOGY, 2013, 144 (05) : S78 - S78
  • [36] Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations
    Steele-Stallard, Heather B.
    Pinton, Luca
    Sarcar, Shilpita
    Ozdemir, Tanel
    Maffioletti, Sara M.
    Zammit, Peter S.
    Tedesco, Francesco Saverio
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [37] Human pluripotent stem cells: Towards therapeutic development for the treatment of lifestyle diseases
    Nishio, Miwako
    Nakahara, Masako
    Yuo, Akira
    Saeki, Kumiko
    WORLD JOURNAL OF STEM CELLS, 2016, 8 (02): : 56 - 61
  • [38] Modeling human extraembryonic mesoderm cells using naive pluripotent stem cells
    Pham, Thi Xuan Ai
    Panda, Amitesh
    Kagawa, Harunobu
    To, San Kit
    Ertekin, Cankat
    Georgolopoulos, Grigorios
    van Knippenberg, Sam S. F. A.
    Allsop, Ryan Nicolaas
    Bruneau, Alexandre
    Chui, Jonathan Sai-Hong
    Vanheer, Lotte
    Janiszewski, Adrian
    Chappell, Joel
    Oberhuemer, Michael
    Tchinda, Raissa Songwa
    Talon, Irene
    Khodeer, Sherif
    Rossant, Janet
    Lluis, Frederic
    David, Laurent
    Rivron, Nicolas
    Balaton, Bradley Philip
    Pasque, Vincent
    CELL STEM CELL, 2022, 29 (09) : 1346 - +
  • [39] Modeling human infertility with pluripotent stem cells
    Chen, Di
    Gell, Joanna J.
    Tao, Yu
    Sosa, Enrique
    Clark, Amander T.
    STEM CELL RESEARCH, 2017, 21 : 187 - 192
  • [40] MODELING HUMAN HEMATOPOIESIS IN PLURIPOTENT STEM CELLS
    Elefanty, Andrew
    Ng, Elizabeth
    Bruveris, Freya
    Azzola, Lisa
    Phipson, Belinda
    Vlahos, Katerina
    Leuitoguinho, Ana Rita
    Calvanese, Vincenzo
    Schenke-Layland, Katja
    Oshlack, Alicia
    Mikkola, Hanna
    Stanley, Edouard
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S30 - S30